Sort
48,018 grants matching “immunotherapy”
Defining the role of NF1 and SPRED1 loss in melanoma
$545,876Iwei Yeh · University Of California, San Francisco · R37 · FY2021 · CA
Combination of ceramide and immunotherapy in treatment of hepatocellular cancer
$545,802Kevin Finnbar Staveleyo'carroll · University Of Missouri-Columbia · R01 · FY2018 · CA
POTENTIATING IMMUNOTHERAPY IN MICROSATELLITE-STABLE COLORECTAL CANCER
$545,786University Of Texas At Austin · · FY2020 · Defense Health Agency
Cell migration and cell-cell interactions in bone marrow
$545,722Ulrich H Von Andrian · Immune Disease Institute, Inc. · P01 · FY2007 · HL
TARGETING ANGIOGENESIS WITH TOXIN VEGF FUSION PROTEINS
$545,700Sibtech, Inc. · R44 · FY2001 · CA
Development of tolerogenic Factor VIII as immunotherapy to prevent inhibitor development in Hemophilia A
$545,700Sathy Venkat Balu-Iyer · State University Of New York At Buffalo · R61 · FY2024 · HL
The role of antibody and the Fc neonatal receptor in transmitted/founder strain selection
$545,573Donald N Forthal · University Of California-Irvine · R01 · FY2015 · AI
Determining how a Werner helicase (WRN) tumor suppressor complex regulates the human papillomavirus 16 life cycle
$545,526Iain Morgan · Virginia Commonwealth University · R01 · FY2024 · DE
A SIM2s/SEMA7A Switch Drives ER+ Breast Cancer Progression
$545,485Traci Lyons · University Of Colorado Denver · R01 · FY2025 · CA
A New Immune Checkpoint Pathway in Human Bladder Cancer
$545,478Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2023 · CA
A New Immune Checkpoint Pathway in Human Bladder Cancer
$545,478Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2025 · CA
Identifying and targeting neoantigens in aggressive salivary carcinomas
$545,430Luc Gordon Trang Morris · Sloan-Kettering Inst Can Research · R01 · FY2020 · DE
In Vitro Approach To Problems of Clinical Allergy
$545,415Johns Hopkins University · R01 · FY2003 · AI
Hexokinase 2 and cancer therapy
$545,313Nissim Hay · University Of Illinois At Chicago · R01 · FY2024 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$545,246Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2023 · CA
Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio
$545,205Claudio Anasetti · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2016 · HL
Early interventions at ART initiation to reduce the HIV-1 reservoir and enhance adaptive immune responses
$545,151Michael R Betts · University Of Pennsylvania · R01 · FY2025 · AI
Immunologic Responses to Cow's Milk Proteins in IgE-mediated Cow's Milk Allergy
$545,092Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2009 · AI
Cooperation of Co-Amplified Genes in Hepatocellular Carcinoma
$545,014Devanand Sarkar · Virginia Commonwealth University · P01 · FY2024 · CA
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
$544,924Boris Reizis · New York University School Of Medicine · R37 · FY2022 · AI
Molecular basis of recognition in the Immunological Synapse
$544,916Andras Fiser · Albert Einstein College Of Medicine · R35 · FY2020 · GM
Bioinformatic Tools for Interpretation of Glycan Array Data
$544,916Jian Zhang · Z Biotech, Llc · R44 · FY2022 · GM
Bioinformatic Tools for Interpretation of Glycan Array Data
$544,916Jian Zhang · Z Biotech, Llc · R44 · FY2023 · GM
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206
$544,855Hyung L Kim · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA
JAML: A New Costimulatory Molecule for Gamma Delta T Cells
$544,850Wendy L Havran · Scripps Research Institute, The · R01 · FY2014 · AI